According to BioNTech's CEO Ugur Sahin, the coronavirus vaccine should be able to adapt swiftly in reaction to the Omicron form, and shots should continue to protect patients from severe sickness despite the mutation.

BioNTech and Pfizer collaborated to develop one of the earliest COVID-19 vaccines, with well over 2 billion doses administered to protect individuals all over the world.

There are fears that the vaccines would fail to protect against the Omicron form, which was discovered last month.

"This variation may be able to infect persons who have been immunized. Infected patients who have been vaccinated should still be protected from serious disease, according to our predictions "In an interview at a major Newswire Next conference on Friday, Sahin said.

The BioNTech CEO, whose work centered on cancer until the COVID-19 coronavirus surfaced in 2020, said the new variety had emerged sooner than he had expected.BioNTech CEO Confident of Quickly Adapting Vaccine for Omicron | Top News | US News

"This extremely mutated virus arrived far sooner than I had anticipated. I had expected it to arrive next year, but it has already arrived."

Sahin also stated that due to modifications in the virus, yearly immunizations would be more likely, as is the case with seasonal flu, and that a new COVID-19 vaccine would be required, though it was unclear when.

"In principle, I believe we will require a new vaccine against this new variety at some point in the future. The question is how quickly it must be made available "Sahin remarked.

Much is unclear about Omicron, which was originally discovered in southern Africa last month and has now been found in at least two dozen countries, just as portions of Europe were dealing with a wave of Delta variant illnesses.

"We believe that this variety may be able to infect people who have been vaccinated and that it will most likely be able to infect people who have had a lot of exposure. One of the things that is becoming increasingly evident is this. It's unclear whether this type causes more severe symptoms "Sahin remarked.

When asked how infectious the Omicron variant might be, Ozlem Tureci, BioNTech's chief medical officer and co-founder, said, "This is something we have to learn with the passage of time, and with the passage of time, I mean really in the daily, weekly horizon, and experts are closely monitoring that."